Nirav N Shah (Nirav Shah)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 55

Top Topics

Cerebrospinal Fluid

Chronic Lymphocytic Leukemia

Top Venues

Bone marrow transplantation

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Saurabh Chhabra, James H Jerkins, Kathleen Monahan, Aniko Szabo, Nirav N Shah, Sameem Abedin, Lyndsey Runaas, Timothy S Fenske, Marcelo C Pasquini, Bronwen E Shaw, Williams R Drobyski, Wael Saber, Anita D Souza, Binod Dhakal, Meera Mohan, Walter Longo, Mehdi Hamadani
Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantation. Bone marrow transplantation 59 (3) (2024)
Mazyar Shadman, Kwang W Ahn, Manmeet Kaur, Lazaros Lekakis, Amer Beitinjaneh, Madiha Iqbal, Nausheen Ahmed, Brian Hill, Nasheed M Hossain, Peter A Riedell, Ajay K Gopal, Natalie Sophia Grover, Matthew Frigault, Jonathan Brammer, Nilanjan Ghosh, Reid W Merryman, Aleksander Lazaryan, Ron Ram, Mark Hertzberg, Bipin P Savani, Farrukh Awan, Farhad Khimani, Sairah A Ahmed, Vaishalee P Kenkre, Matthew L Ulrickson, Nirav N Shah, Mohamed A Kharfan-Dabaja, Alex Herrera, Craig Sauter, Mehdi Hamadani
Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission. Blood cancer journal 14 (1) (2024)
Meera Mohan, Aniko Szabo, Anannya Patwari, Jean Esselmann, Tanvi Patel, Ramya Bachu, Lisa E Rein, Abhishek Janardan, Vineel Bhatlapenumarthi, Evanka Annyapu, Catherine Skoog, Areyl Goff, Samer Al Hadidi, Sabarinath Venniyil Radhakrishnan, Sharmilan Thanendrarajan, Maurizio Zangari, Nirav N Shah, Frits Van Rhee, Binod Dhakal, Mehdi Hamadani, Anita D Souza, Carolina D Schinke
Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma. Bone marrow transplantation 59 (5) (2024)
Mazyar Shadman, Kwang W Ahn, Manmeet Kaur, Lazaros Lekakis, Amer Beitinjaneh, Madiha Iqbal, Nausheen Ahmed, Brian Hill, Nasheed M Hossain, Peter A Riedell, Ajay K Gopal, Natalie Sophia Grover, Matthew Frigault, Jonathan Brammer, Nilanjan Ghosh, Reid W Merryman, Aleksander Lazaryan, Ron Ram, Mark Hertzberg, Bipin P Savani, Farrukh Awan, Farhad Khimani, Sairah A Ahmed, Vaishalee P Kenkre, Matthew L Ulrickson, Nirav N Shah, Mohamed A Kharfan-Dabaja, Alex Herrera, Craig Sauter, Mehdi Hamadani
Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission. Blood cancer journal 14 (1) (2024)
Saurabh Chhabra, James H Jerkins, Kathleen Monahan, Aniko Szabo, Nirav N Shah, Sameem Abedin, Lyndsey Runaas, Timothy S Fenske, Marcelo C Pasquini, Bronwen E Shaw, Williams R Drobyski, Wael Saber, Anita D Souza, Binod Dhakal, Meera Mohan, Walter Longo, Mehdi Hamadani
Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantation. Bone marrow transplantation 59 (3) (2024)
Meera Mohan, Aniko Szabo, Anannya Patwari, Jean Esselmann, Tanvi Patel, Ramya Bachu, Lisa E Rein, Abhishek Janardan, Vineel Bhatlapenumarthi, Evanka Annyapu, Catherine Skoog, Areyl Goff, Samer Al Hadidi, Sabarinath Venniyil Radhakrishnan, Sharmilan Thanendrarajan, Maurizio Zangari, Nirav N Shah, Frits Van Rhee, Binod Dhakal, Mehdi Hamadani, Anita D Souza, Carolina D Schinke
Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma. Bone marrow transplantation (2024)
Reem Karmali, Rushad Machhi, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Tamara K Moyo, Vaishalee P Kenkre, Thomas A Ollila, Lindsey A Fitzgerald, Brian T Hess, Kevin A David, Ishan Roy, Joanna C Zurko, Sayan Mullick Chowdhury, Kaitlin Annunzio, Robert Ferdman, Rahul S Bhansali, Elyse I Harris, Jieqi Liu, Imran A Nizamuddin, Shuo Ma, Jonathan Moreira, Jane N Winter, Barbara Pro, Deborah M Stephens, Alexey V Danilov, Nirav N Shah, Jonathon B Cohen, Stefan K Barta, Pallawi Torka, Leo I Gordon
Impact of Race and Social Determinants of Health on Outcomes in Patients with Aggressive B-cell nHL Treated with CAR-T. Blood advances (2024)
Meera Mohan, Aniko Szabo, Anannya Patwari, Jean Esselmann, Tanvi Patel, Ramya Bachu, Lisa E Rein, Abhishek Janardan, Vineel Bhatlapenumarthi, Evanka Annyapu, Catherine Skoog, Areyl Goff, Samer Al Hadidi, Sabarinath Venniyil Radhakrishnan, Sharmilan Thanendrarajan, Maurizio Zangari, Nirav N Shah, Frits Van Rhee, Binod Dhakal, Mehdi Hamadani, Anita D Souza, Carolina D Schinke
Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma. Bone marrow transplantation 59 (5) (2024)
Álvaro Urbano-Ispizua, Nirav N Shah, Natasha Kekre
Point-of-Care CAR-T Manufacturing Solutions: Can One Model Fit All? Blood advances (2024)
Lindsey Elizabeth Roeker, Jennifer A Woyach, Chan Yoon Y Cheah, Catherine C Coombs, Nirav N Shah, William G Wierda, Manish R Patel, Nicole Lamanna, Donald E Tsai, Binoj Chandrasekharan Nair, Chunxiao Wang, Xiang Zhao, Dan Liu, David Radtke, Sonya Chapman, Narasimha Marella, Samuel C McNeely, Jennifer R Brown
Fixed-Duration Pirtobrutinib plus Venetoclax with or without Rituximab in Relapsed/Refractory CLL: Phase 1b BRUIN Trial. Blood (2024)
Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji, Loretta J Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy L Bartlett, Victoria R Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua D Brody, Jeremy S Abramson, Matthew A Lunning, Nirav N Shah, Ayed Ayed, Manali Kamdar, Benjamin M Parsons, Paolo Caimi, Ian W Flinn, Alex F Herrera, Jeff P Sharman, Marshall McKenna, Philippe Armand, Brad S Kahl, Sonali M Smith, Andrew D Zelenetz, L Elizabeth Elizabeth Budde, Martin Hutchings, Tycel Jovelle Phillips, Michael J Dickinson
Consensus Recommendations on the Management of Toxicity Associated with CD3xCD20 Bispecific Antibody Therapy. Blood (2024)
Reem Karmali, Rushad Machhi, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Tamara K Moyo, Vaishalee Kenkre, Thomas A Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A David, Ishan Roy, Joanna C Zurko, Sayan Mullick Chowdhury, Kaitlin Annunzio, Robert Ferdman, Rahul S Bhansali, Elyse I Harris, Jieqi Liu, Imran Nizamuddin, Shuo Ma, Jonathan Moreira, Jane Winter, Barbara Pro, Deborah M Stephens, Alexey Danilov, Nirav N Shah, Jonathon B Cohen, Stefan K Barta, Pallawi Torka, Leo I Gordon
Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy. Blood advances 8 (10) (2024)
Megan Melody, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Pamela Blair Allen, Tamara K Moyo, Vaishalee Kenkre, Thomas A Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A David, Megan M Herr, Oluwatobi Odetola, Adam Yuh Lin, Jonathan Moreira, Shuo Ma, Jane N Winter, Ishan Roy, Deborah M Stephens, Alexey Danilov, Nirav N Shah, Stefan K Barta, Matthew Cortese, Jonathon B Cohen, Leo I Gordon, Reem Karmali
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy. Blood advances 8 (10) (2024)
Mazyar Shadman, Kwang W Ahn, Manmeet Kaur, Lazaros Lekakis, Amer Beitinjaneh, Madiha Iqbal, Nausheen Ahmed, Brian Hill, Nasheed M Hossain, Peter A Riedell, Ajay K Gopal, Natalie Sophia Grover, Matthew Frigault, Jonathan Brammer, Nilanjan Ghosh, Reid W Merryman, Aleksander Lazaryan, Ron Ram, Mark Hertzberg, Bipin P Savani, Farrukh Awan, Farhad Khimani, Sairah A Ahmed, Vaishalee P Kenkre, Matthew L Ulrickson, Nirav N Shah, Mohamed A Kharfan-Dabaja, Alex Herrera, Craig Sauter, Mehdi Hamadani
Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission. Blood cancer journal 14 (1) (2024)
Meera Mohan, Aniko Szabo, Anannya Patwari, Jean Esselmann, Tanvi Patel, Ramya Bachu, Lisa E Rein, Abhishek Janardan, Vineel Bhatlapenumarthi, Evanka Annyapu, Catherine Skoog, Areyl Goff, Samer Al Hadidi, Sabarinath Venniyil Radhakrishnan, Sharmilan Thanendrarajan, Maurizio Zangari, Nirav N Shah, Frits Van Rhee, Binod Dhakal, Mehdi Hamadani, Anita D Souza, Carolina D Schinke
Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma. Bone marrow transplantation 59 (5) (2024)
Megan Melody, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Pamela Blair Allen, Tamara K Moyo, Vaishalee Kenkre, Thomas A Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A David, Megan M Herr, Oluwatobi Odetola, Adam Yuh Lin, Jonathan Moreira, Shuo Ma, Jane N Winter, Ishan Roy, Deborah M Stephens, Alexey Danilov, Nirav N Shah, Stefan K Barta, Matthew Cortese, Jonathon B Cohen, Leo I Gordon, Reem Karmali
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy. Blood advances 8 (10) (2024)
Reem Karmali, Rushad Machhi, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Tamara K Moyo, Vaishalee Kenkre, Thomas A Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A David, Ishan Roy, Joanna C Zurko, Sayan Mullick Chowdhury, Kaitlin Annunzio, Robert Ferdman, Rahul S Bhansali, Elyse I Harris, Jieqi Liu, Imran Nizamuddin, Shuo Ma, Jonathan Moreira, Jane Winter, Barbara Pro, Deborah M Stephens, Alexey Danilov, Nirav N Shah, Jonathon B Cohen, Stefan K Barta, Pallawi Torka, Leo I Gordon
Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy. Blood advances 8 (10) (2024)
Megan Melody, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Pamela Blair Allen, Tamara K Moyo, Vaishalee Kenkre, Thomas A Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A David, Megan M Herr, Oluwatobi Odetola, Adam Yuh Lin, Jonathan Moreira, Shuo Ma, Jane N Winter, Ishan Roy, Deborah M Stephens, Alexey Danilov, Nirav N Shah, Stefan K Barta, Matthew Cortese, Jonathon B Cohen, Leo I Gordon, Reem Karmali
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy. Blood advances 8 (10) (2024)
Saurabh Chhabra, James H Jerkins, Kathleen Monahan, Aniko Szabo, Nirav N Shah, Sameem Abedin, Lyndsey Runaas, Timothy S Fenske, Marcelo C Pasquini, Bronwen E Shaw, Williams R Drobyski, Wael Saber, Anita D Souza, Binod Dhakal, Meera Mohan, Walter Longo, Mehdi Hamadani
Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantation. Bone marrow transplantation (2024)
Lindsey Elizabeth Roeker, Jennifer A Woyach, Chan Yoon Y Cheah, Catherine C Coombs, Nirav N Shah, William G Wierda, Manish R Patel, Nicole Lamanna, Donald E Tsai, Binoj Chandrasekharan Nair, Chunxiao Wang, Xiang Zhao, Dan Liu, David Radtke, Sonya Chapman, Narasimha Marella, Samuel C McNeely, Jennifer R Brown
Fixed-Duration Pirtobrutinib plus Venetoclax with or without Rituximab in Relapsed/Refractory CLL: Phase 1b BRUIN Trial. Blood (2024)
Fateeha Furqan, Vineel Bhatlapenumarthi, Binod Dhakal, Timothy S Fenske, Faiqa Farrukh, Walter Longo, Othman Akhtar, Anita D'Souza, Marcelo C Pasquini, Guru Subramanian Guru Murthy, Lyndsey Runaas, Sameem Abedin, Meera Mohan, Nirav N Shah, Mehdi Hamadani
Outpatient administration of CAR T-cell therapies using a strategy of no remote monitoring and early CRS intervention. Blood advances 8 (16) (2024)
Reem Karmali, Rushad Machhi, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Tamara K Moyo, Vaishalee Kenkre, Thomas A Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A David, Ishan Roy, Joanna C Zurko, Sayan Mullick Chowdhury, Kaitlin Annunzio, Robert Ferdman, Rahul S Bhansali, Elyse I Harris, Jieqi Liu, Imran Nizamuddin, Shuo Ma, Jonathan Moreira, Jane Winter, Barbara Pro, Deborah M Stephens, Alexey Danilov, Nirav N Shah, Jonathon B Cohen, Stefan K Barta, Pallawi Torka, Leo I Gordon
Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy. Blood advances 8 (10) (2024)
Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji, Loretta J Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy L Bartlett, Victoria Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua D Brody, Jeremy S Abramson, Matthew A Lunning, Nirav N Shah, Ayed Ayed, Manali Kamdar, Benjamin Parsons, Paolo F Caimi, Ian W Flinn, Alex F Herrera, Jeffrey Sharman, Marshall McKenna, Philippe Armand, Brad S Kahl, Sonali M Smith, Andrew D Zelenetz, L Elizabeth Elizabeth Budde, Martin Hutchings, Tycel Jovelle Phillips, Michael J Dickinson
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy. Blood 143 (16) (2024)
Lindsey Elizabeth Roeker, Jennifer A Woyach, Chan Yoon Y Cheah, Catherine C Coombs, Nirav N Shah, William G Wierda, Manish R Patel, Nicole Lamanna, Donald E Tsai, Binoj Chandrasekharan Nair, Chunxiao Wang, Xiang Zhao, Dan Liu, David Radtke, Sonya Chapman, Narasimha Marella, Samuel C McNeely, Jennifer R Brown
Fixed-Duration Pirtobrutinib plus Venetoclax with or without Rituximab in Relapsed/Refractory CLL: Phase 1b BRUIN Trial. Blood (2024)
Fateeha Furqan, Vineel Bhatlapenumarthi, Binod Dhakal, Timothy S Fenske, Faiqa Farrukh, Walter Longo, Othman Akhtar, Anita D'Souza, Marcelo C Pasquini, Guru Subramanian Guru Murthy, Lyndsey Runaas, Sameem Abedin, Meera Mohan, Nirav N Shah, Mehdi Hamadani
Outpatient administration of CAR T-cell therapies using a strategy of no remote monitoring and early CRS intervention. Blood advances 8 (16) (2024)
Fateeha Furqan, Vineel Bhatlapenumarthi, Binod Dhakal, Timothy S Fenske, Faiqa Farrukh, Walter Longo, Othman Salim Akhtar, Anita D'Souza, Marcelo C Pasquini, Guru Subramanian Guru Murthy, Lyndsey Runaas, Sameem Abedin, Meera Mohan, Nirav N Shah, Mehdi Hamadani
Outpatient Administration of CAR T-cell Therapies Using a Strategy of No Remote Monitoring and Early CRS Intervention. Blood advances (2024)
Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji, Loretta J Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy L Bartlett, Victoria R Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua D Brody, Jeremy S Abramson, Matthew A Lunning, Nirav N Shah, Ayed Ayed, Manali Kamdar, Benjamin M Parsons, Paolo Caimi, Ian W Flinn, Alex F Herrera, Jeff P Sharman, Marshall McKenna, Philippe Armand, Brad S Kahl, Sonali M Smith, Andrew D Zelenetz, L Elizabeth Elizabeth Budde, Martin Hutchings, Tycel Jovelle Phillips, Michael J Dickinson
Consensus Recommendations on the Management of Toxicity Associated with CD3xCD20 Bispecific Antibody Therapy. Blood (2024)
Megan Melody, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Pamela Blair Allen, Tamara K Moyo, Vaishalee Kenkre, Thomas A Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A David, Megan M Herr, Oluwatobi Odetola, Adam Yuh Lin, Jonathan Moreira, Shuo Ma, Jane N Winter, Ishan Roy, Deborah M Stephens, Alexey Danilov, Nirav N Shah, Stefan K Barta, Matthew Cortese, Jonathon B Cohen, Leo I Gordon, Reem Karmali
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy. Blood advances 8 (10) (2024)
Megan Melody, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Pamela Blair Allen, Tamara K Moyo, Vaishalee P Kenkre, Thomas A Ollila, Lindsey A Fitzgerald, Brian T Hess, Kevin A David, Megan M Herr, Oluwatobi Odetola, Adam Yuh Lin, Jonathan Moreira, Shuo Ma, Jane N Winter, Ishan Roy, Deborah M Stephens, Alexey V Danilov, Nirav N Shah, Stefan K Barta, Matthew J Cortese, Jonathon B Cohen, Leo I Gordon, Reem Karmali
Subsequent Malignant Neoplasms in Patients Previously Treated with Anti-CD19 CAR T-Cell Therapy. Blood advances (2024)
Jackson T Bowers, Jacob L Anna, Steven M Bair, Kaitlin Annunzio, Narendranath Epperla, Jerrin Joy Pullukkara, Sameh Gaballa, Michael A Spinner, Shuning Li, Marcus R Messmer, Joseph Dan Khoa Nguyen, Emily C Ayers, Charlotte B Wagner, Boyu Hu, Mengyang Di, Scott F Huntington, Fateeha Furqan, Nirav N Shah, Christina Chen, Hatcher J Ballard, Mitchell E Hughes, Elise A Chong, Sunita D Nasta, Stefan K Barta, Daniel J Landsburg, Jakub Svoboda
Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort. Blood advances (2023)
Michael J Dickinson, Pere Barba, Ulrich Jäger, Nirav N Shah, Didier Blaise, Javier Briones, Leyla Shune, Nicolas Boissel, Attilio Bondanza, Luisa Mariconti, Anne-Laure Marchal, David S Quinn, Jennifer Yang, Andrew Price, Akash Sohoni, Louise M Treanor, Elena J Orlando, Jennifer Mataraza, Jaclyn Davis, Darlene Lu, Xu Zhu, Boris Engels, Laure Moutouh-de Parseval, Jennifer L Brogdon, Michele Moschetta, Ian W Flinn
A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-Cell Stemness Shows Enhanced CAR T-Cell Efficacy in Preclinical and Early Clinical Development. Cancer discovery (2023)
Michael L Wang, Wojciech Jurczak, Pier Luigi Luigi Zinzani, Toby Andrew Eyre, Chan Yoon Y Cheah, Chaitra S Ujjani, Youngil Koh, Koji Izutsu, James N Gerson, Ian W Flinn, Benoît Tessoulin, Alvaro J Alencar, Shuo Ma, David John Lewis, Ewa Lech-Maranda, Joanna M Rhodes, Krish Patel, Kami Maddocks, Nicole Lamanna, Yucai Wang, Constantine S Tam, Tahla Munir, Hirokazu Nagai, Francisco Hernandez-Ilizaliturri, Anita Kumar, Timothy S Fenske, John Francis Seymour, Andrew D Zelenetz, Binoj Nair, Donald E Tsai, Minna Balbas, Richard A Walgren, Paolo Abada, Chunxiao Wang, Junjie Zhao, Anthony R Mato, Nirav N Shah
Pirtobrutinib in Covalent BTK-Inhibitor Pre-treated Mantle Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Lindsay Hammons, Shabi Haider, Andrew Jay Portuguese, Rahul Banerjee, Aniko Szabo, Marcelo C Pasquini, Saurabh Chhabra, Sabarinath Radhakrishnan, Meera Mohan, Ravi Narra, Jing Dong, Siegfried Janz, Nirav N Shah, Mehdi Hamadani, Anita D Souza, Parameswaran Hari, Binod Dhakal
Chimeric antigen receptor and bispecific T-cell engager therapies in multiple myeloma patients with prior allogeneic transplantation. British journal of haematology (2023)
Anthony R Mato, Jennifer A Woyach, Jennifer R Brown, Paolo Ghia, Krish Patel, Toby A Eyre, Talha Munir, Ewa Lech-Maranda, Nicole Lamanna, Constantine S Tam, Nirav N Shah, Catherine C Coombs, Chaitra S Ujjani, Bita Fakhri, Chan Yoon Y Cheah, Manish R Patel, Alvaro J Alencar, Jonathon B Cohen, James N Gerson, Ian W Flinn, Shuo Ma, Deepa Jagadeesh, Joanna M Rhodes, Francisco Hernandez-Ilizaliturri, Pier L Zinzani, John Francis Seymour, Minna Balbas, Binoj Nair, Paolo Abada, Chunxiao Wang, Amy S Ruppert, Denise Wang, Donald E Tsai, William G Wierda, Wojciech Jurczak
Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia. The New England journal of medicine 389 (1) (2023)
Troy J Kenkel, Nithya Sridhar, Lindsay R Hammons, Maria Hintzke, Nirav N Shah
Bone Marrow Aplasia after CAR-T-Cell Therapy for Relapsed/Refractory Burkitt's Lymphoma. Medical sciences (Basel, Switzerland) 11 (4) (2023)
Joanna C Zurko, Imran Nizamuddin, Narendranath Epperla, Kevin A David, Jonathon B Cohen, Tamara Moyo, Thomas A Ollila, Brian T Hess, Ishan Roy, Robert Ferdman, Jieqi Liu, Sayan Mullick Chowdhury, Jason T Romancik, Rahul S Bhansali, Elyse I Harris, Mckenzie Sorrell, Rebecca Masel, Adam S Kittai, Nathan Denlinger, Audrey M Sigmund, Lindsey A Fitzgerald, Carlos Galvez, Shuo Ma, Jane N Winter, Barbara Pro, Leo I Gordon, Alexey V Danilov, Deborah M Stephens, Nirav N Shah, Vaishalee P Kenkre, Stefan K Barta, Pallawi Torka, Geoffrey Shouse, Reem Karmali
Peri-CAR-T practice patterns and survival predictors for all CAR-T patients and post-CAR-T failure in aggressive B-NHL. Blood advances (2022)
Jennifer Mary Knight, Aniko Szabo, Igli Arapi, Ruizhe Wu, Amanda Emmrich, Edward Hackett, Garrett Sauber, Sharon Yim, Bryon Johnson, Parameswaran N Hari, Dina Schneider, Boro Dropulic, Rachel N Cusatis, Steve W Cole, Cecilia J Hillard, Nirav N Shah
Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapy. Communications medicine 2 (2022)
Jennifer Mary Knight, Aniko Szabo, Igli Arapi, Ruizhe Wu, Amanda Emmrich, Edward Hackett, Garrett Sauber, Sharon Yim, Bryon Johnson, Parameswaran N Hari, Dina Schneider, Boro Dropulic, Rachel N Cusatis, Steve W Cole, Cecilia J Hillard, Nirav N Shah
Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapy. Communications medicine 2 (1) (2022)
Fateeha Furqan, Morgan Maring, Aniko Szabo, Timothy S Fenske, Mehdi Hamadani, Nirav N Shah
Salvage polatuzumab and allogeneic transplant rescues patients with B-cell lymphoma failing CAR T-cell therapy. Blood advances (2022)
Nirav N Shah, Alexandra M Harrington
Hemophagocytosis in cerebrospinal fluid after CAR T-cell therapy. Blood 139 (7) (2022)
Joanna C Zurko, Timothy S Fenske, Bryon D Johnson, Daniel Bucklan, Aniko Szabo, Huiqing Xu, Katherine Chaney, Mehdi Hamadani, Parameswaran Hari, Nirav N Shah
Long-term outcomes and predictors of early response, late relapse, and survival for patients treated with bispecific LV20.19 CAR T-cells. American journal of hematology 97 (12) (2022)
Thomas Luo, Joanna Zurko, John Astle, Nirav N Shah
Mimicking Myelodysplastic Syndrome: Importance of Differential Diagnosis. Case reports in hematology 2021 (2021)
Bronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, Brent R Logan, Farhad Khimani, Brian C Shaffer, Nirav N Shah, Alisha Mussetter, Xiao-Ying Tang, John M McCarty, Asif Alavi, Nosha Farhadfar, Katarzyna Jamieson, Nancy M Hardy, Hannah Choe, Richard F Ambinder, Claudio Anasetti, Miguel-Ángel Perales, Stephen R Spellman, Alan Howard, Krishna V Komanduri, Leo Luznik, Maxim Norkin, Joseph A Pidala, Voravit Ratanatharathorn, Dennis L Confer, Steven M Devine, Mary M Horowitz, Javier Bolaños-Meade
National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (18) (2021)
Robert J Cronk, Joanna C Zurko, Nirav N Shah
Bispecific Chimeric Antigen Receptor T Cell Therapy for B Cell Malignancies and Multiple Myeloma. Cancers 12 (9) (2020)
Nirav N Shah, Bryon D Johnson, Dina Schneider, Fenlu Zhu, Aniko Szabo, Carolyn A Keever-Taylor, Winfried Krueger, Andrew A Worden, Michael J Kadan, Sharon Yim, Ashley Cunningham, Mehdi Hamadani, Timothy S Fenske, Boro Dropulić, Rimas Orentas, Parameswaran Hari
Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial. Nature medicine 26 (10) (2020)
Antonio Cuneo, Anthony R Mato, Gian Matteo Rigolin, Alfonso Piciocchi, Massimo Gentile, Luca Laurenti, John N Allan, John M Pagel, Danielle M Brander, Brian T Hill, Allison M Winter, Nicole Lamanna, Constantine S Tam, Ryan Jacobs, Frederick Lansigan, Paul M Barr, Mazyar Shadman, Alan P Skarbnik, Jeffrey J Pu, Alison R Sehgal, Stephen J Schuster, Nirav N Shah, Chaitra S Ujjani, Lindsey Roeker, Ester Maria Orlandi, Atto Billio, Livio Trentin, Martin Spacek, Monia Marchetti, Alessandra Tedeschi, Fiorella Ilariucci, Gianluca Gaidano, Michael Doubek, Lucia Farina, Stefano Molica, Francesco Di Raimondo, Marta Coscia, Francesca Romana Mauro, Javier de la Serna, Angeles Medina Perez, Isacco Ferrarini, Giuseppe Cimino, Maurizio Cavallari, Rosalba Cucci, Marco Vignetti, Robin Foà, Paolo Ghia, null null
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study. Cancer medicine 9 (22) (2020)
Guru Subramanian Guru Murthy, Aniko Szabo, Mehdi Hamadani, Timothy S Fenske, Nirav N Shah
Contemporary Outcomes for Advanced-Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results Database. The oncologist 24 (11) (2019)
Adam Levin, Nirav N Shah
Chimeric antigen receptor modified T cell therapy in B cell non-Hodgkin lymphomas. American journal of hematology 94 (S1) (2019)
Nirav N Shah, Arun K Singavi, Alexandra Harrington
Daratumumab in Primary Effusion Lymphoma. The New England journal of medicine 379 (7) (2018)
Anthony R Mato, Lindsey E Roeker, John N Allan, John M Pagel, Danielle M Brander, Brian T Hill, Bruce D Cheson, Richard R Furman, Nicole Lamanna, Constantine S Tam, Sasanka Handunnetti, Ryan Jacobs, Frederick Lansigan, Erica Bhavsar, Paul M Barr, Mazyar Shadman, Alan P Skarbnik, Andre Goy, Douglas F Beach, Jakub Svoboda, Jeffrey J Pu, Alison R Sehgal, Clive S Zent, Hande H Tuncer, Stephen J Schuster, Peter V Pickens, Nirav N Shah, Joanna Rhodes, Chaitra S Ujjani, Chadi Nabhan
Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial. American journal of hematology 93 (11) (2018)
Arun K Singavi, Nirav N Shah
Graft-versus-host disease-associated hepatic portal venous gas. British journal of haematology 181 (1) (2018)
Nirav N Shah, Timothy S Fenske, Mehdi Hamadani, Jakub Svoboda
What is the standard of care for primary mediastinal B cell lymphoma; R-CHOP or DA-EPOCH-R? - Response to Melani et al. British journal of haematology 184 (5) (2018)
Nirav N Shah, Aniko Szabo, Scott F Huntington, Narendranath Epperla, Nishitha Reddy, Siddhartha Ganguly, Julie Vose, Cynthia Obiozor, Fahad Faruqi, Alexandra E Kovach, Luciano José Megale Costa, Ana C Xavier, Ryan Okal, Abraham S Kanate, Nilanjan Ghosh, Mohamed A Kharfan-Dabaja, Lauren Strelec, Mehdi Hamadani, Timothy S Fenske, Oscar Calzada, Jonathon B Cohen, Julio Chavez, Jakub Svoboda
R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma: a multi-centre analysis. British journal of haematology 180 (4) (2017)
James H Jerkins, Mehdi Hamadani, Felicia Zook, Narendranath Epperla, Bronwen E Shaw, Wael Saber, J Douglas Rizzo, Marcelo Pasquini, Saurabh Chhabra, William R Drobyski, Parameswaran N Hari, Nirav N Shah
Alpha-1-antitrypsin for the treatment of steroid-refractory acute gastrointestinal graft-versus-host disease. American journal of hematology 92 (10) (2017)
Jillian Sinkoff, Horatiu Olteanu, Jess F Peterson, Nirav N Shah
Leukemic phase and CSF involvement of diffuse large B-cell lymphoma with a complex karyotype including a TP53 deletion. Clinical case reports 6 (1) (2017)